Skip to main content

Karen A. Cashmere

Chief Commercial Officer

Other

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 ZyVersa Therapeutics, Inc. (ZVSA) $320,000 $486,687
2022 ZyVersa Therapeutics, Inc. (ZVSA) $300,000 $582,622

Earnings-call appearances

No earnings-call appearances recorded yet.